MedTrace Logo

Phage Safety Retrospective Cohort Study

NCT04724603 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-04-13

No results posted yet for this study

Summary

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

Conditions

  • Bone and Joint Infection
  • Prosthetic Joint Infection

Interventions

OTHER

patients having had avderse event after phagotherapy for bone or joint or implant infection

to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-08-01
Completion
2026-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724603 on ClinicalTrials.gov